Rafferty Asset Management, LLC - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 152 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
Rafferty Asset Management, LLC ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$1,712,176
+13.1%
58,576
+2.2%
0.01%
-12.5%
Q3 2022$1,514,000
+63.7%
57,304
+175.1%
0.02%
+77.8%
Q2 2022$925,000
-35.3%
20,829
-27.9%
0.01%
+12.5%
Q1 2022$1,429,000
-13.1%
28,874
-10.6%
0.01%
-11.1%
Q4 2021$1,644,000
+54.2%
32,295
+68.9%
0.01%
+28.6%
Q3 2021$1,066,000
+17.1%
19,118
-10.0%
0.01%
+16.7%
Q2 2021$910,000
-30.2%
21,254
-31.9%
0.01%
-33.3%
Q1 2021$1,303,000
+272.3%
31,209
+315.5%
0.01%
+200.0%
Q4 2020$350,000
-57.4%
7,512
-61.2%
0.00%
-70.0%
Q3 2020$822,000
+98.1%
19,340
+123.6%
0.01%
+66.7%
Q2 2020$415,000
-57.2%
8,648
-46.4%
0.01%
-60.0%
Q4 2019$970,000
-28.6%
16,144
-32.7%
0.02%
-28.6%
Q3 2019$1,358,000
-28.9%
24,002
-30.1%
0.02%
-38.2%
Q2 2019$1,911,000
+42.9%
34,326
+29.6%
0.03%
+54.5%
Q1 2019$1,337,000
+72.7%
26,480
+103.9%
0.02%
+29.4%
Q3 2017$774,00012,9850.02%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Park West Asset Management LLC 1,120,235$53,749,0002.66%
TANG CAPITAL MANAGEMENT LLC 255,616$12,264,0001.19%
Smith, Graham & Co., Investment Advisors, LP 158,671$7,613,0000.92%
ARMISTICE CAPITAL, LLC 282,000$13,530,0000.59%
Capital Impact Advisors, LLC 35,815$1,718,0000.57%
Matarin Capital Management, LLC 58,977$2,830,0000.56%
GLOBEFLEX CAPITAL L P 31,702$1,521,0000.39%
CHARTWELL INVESTMENT PARTNERS, LLC 200,246$9,608,0000.37%
Stanley-Laman Group, Ltd. 24,000$1,152,0000.28%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 264$13,0000.20%
View complete list of EAGLE PHARMACEUTICALS INC shareholders